191 related articles for article (PubMed ID: 32953502)
21. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
22. Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis.
Zhang X; Bao L; Yu G; Wang H
Front Surg; 2022; 9():1050242. PubMed ID: 36684253
[TBL] [Abstract][Full Text] [Related]
23. Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.
Shan Y; Ding H; Lu J; Ge Z; Tan Y
Oncotarget; 2017 Dec; 8(68):112809-112815. PubMed ID: 29348867
[TBL] [Abstract][Full Text] [Related]
24. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer.
Wang T; Lv M; Shen S; Zhou S; Wang P; Chen Y; Liu B; Yu L; Hou Y
PLoS One; 2012; 7(8):e43268. PubMed ID: 22937028
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion.
Wu DW; Chang WA; Liu KT; Yen MC; Kuo PL
Oncol Lett; 2017 Sep; 14(3):3657-3662. PubMed ID: 28927127
[TBL] [Abstract][Full Text] [Related]
26. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
Tian T; Li J; Hu W; Sun C; Zhou J
J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
[TBL] [Abstract][Full Text] [Related]
27. A simple and efficient clinical prediction scoring system to identify malignant pleural effusion.
Wang S; An J; Hu X; Zeng T; Li P; Qin J; Shen Y; Wang T; Wen F
Ther Adv Respir Dis; 2024; 18():17534666231223002. PubMed ID: 38189181
[TBL] [Abstract][Full Text] [Related]
28. Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion.
Chen KY; Feng PH; Chang CC; Chen TT; Chuang HC; Lee CN; Su CL; Lin LY; Lee KY
Int J Gen Med; 2016; 9():183-9. PubMed ID: 27354819
[TBL] [Abstract][Full Text] [Related]
29. Cell-Free DNA Methylation Analysis as a Marker of Malignancy in Pleural Fluid.
Bixby B; Vrba L; Lenka J; Oshiro M; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Res Sq; 2023 Oct; ():. PubMed ID: 37886511
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of CD206
Pei XB; Wu XZ; Yi FS; Zhai K; Shi HZ
J Thorac Dis; 2019 Jul; 11(7):2730-2736. PubMed ID: 31463100
[TBL] [Abstract][Full Text] [Related]
31. [Value of PET/MRI in the diagnosis of malignant pleural effusion in comparison with PET/CT].
Peng WB; Sun X; Zhou M; Wei XS; Wu XZ; Ruan WW; Shi HZ; Lan XL; Zhou Q
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2363-2369. PubMed ID: 34404128
[No Abstract] [Full Text] [Related]
32. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
[TBL] [Abstract][Full Text] [Related]
33. Homocysteine: new tumor marker in pleural fluid.
Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S
Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram.
Wu A; Liang Z; Yuan S; Wang S; Peng W; Mo Y; Yang J; Liu Y
Front Oncol; 2021; 11():775079. PubMed ID: 34950585
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
37. A Novel Combination of Calprotectin and CXCL12 for Predicting Malignancy in Patients with Exudative Pleural Effusion.
Luo J; Wang M; Li C; Liang B; Liu D; Shi C; Jiang F; Wang T; Li P; Liang Z
Medicine (Baltimore); 2015 Nov; 94(47):e2105. PubMed ID: 26632726
[TBL] [Abstract][Full Text] [Related]
38. Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.
Zhang F; Wang J; Zheng X; Hu L; Chen J; Jiang F; Wang Y
J Clin Lab Anal; 2018 Oct; 32(8):e22576. PubMed ID: 29797475
[TBL] [Abstract][Full Text] [Related]
39. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.
Xu CH; Zhan P; Yu LK; Zhang XW
Tumour Biol; 2014 Feb; 35(2):1599-603. PubMed ID: 24072496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
